Call Us

    What Are the Signs of Treatment-Resistant Depression?

    Written by Neuro Wellness TMS Centers of AmericaMedically reviewed by Daniel Pietras, MDPublished November 3, 2026Last medically reviewed November 3, 2026Last updated November 3, 2026

    The primary sign of treatment-resistant depression is inadequate response to at least two antidepressant medication trials of adequate dose and duration in the current episode. Other signs include persistent symptoms despite medication, partial response that plateaus, recurring episodes despite treatment, and side effects that prevent adequate dosing. Treatment-resistant depression is not a separate diagnosis — it describes your treatment history. If you suspect treatment-resistant depression, a psychiatric evaluation can confirm whether past trials were adequate and what to try next.

    Key takeaways

    • TRD means inadequate response to ≥2 adequate antidepressant trials.
    • Persistent symptoms despite medication is the key sign.
    • Partial response that plateaus may indicate TRD.
    • TRD is a description of treatment history, not a separate diagnosis.
    • A psychiatric evaluation can confirm whether past trials were adequate.

    The Primary Sign: Inadequate Response to Medication

    The primary sign of treatment-resistant depression is that your depression has not improved adequately after at least two antidepressant medication trials of adequate dose and duration. 'Adequate' means the medication was taken at a therapeutic dose (not just a starting dose) consistently for about 6-8 weeks. A medication stopped early because of side effects is usually considered an incomplete trial, not a failed one.

    If you've tried two or more antidepressants at adequate doses for adequate durations and your depression hasn't improved, you may meet the definition of treatment-resistant depression.

    Other Signs

    Other signs that may indicate treatment-resistant depression include:

    • Persistent symptoms despite taking medication as prescribed
    • Partial response that plateaus — some improvement but not full remission
    • Recurring episodes despite ongoing treatment
    • Side effects that prevent reaching an adequate dose
    • Depression that worsens or returns after initial improvement
    • Multiple medication changes without sustained improvement

    What Treatment-Resistant Depression Is Not

    Treatment-resistant depression is not a separate diagnosis — it is a description of your treatment history. It does not mean your depression cannot be treated. It does not mean you've 'failed' treatment. It means that standard first-line treatments (antidepressants) haven't worked adequately, and other options may be appropriate.

    It also doesn't mean you need to have tried every available treatment. The definition typically requires at least two failed antidepressant trials, not exhaustion of all options.

    What to Do If You Suspect TRD

    If you suspect treatment-resistant depression, ask for a comprehensive psychiatric evaluation. This review confirms whether past medication trials were truly adequate, screens for conditions that can mimic treatment resistance (like bipolar disorder), and identifies what to try next. Options beyond standard antidepressants include TMS, SAINT® accelerated TMS, SPRAVATO® (esketamine), medication optimization, and psychotherapy.

    SAINT by Magnus Medical
    Watch & Learn

    Understanding SAINT® TMS: How It Works & What to Expect

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. These videos explain how it works and how it differs from conventional TMS.

    SAINT® is an FDA-cleared, fMRI-guided form of TMS developed at Stanford. Most patients complete treatment in one week — not the six weeks standard TMS requires.

    Follow a real patient through the five-day SAINT® treatment week

    Is SAINT® TMS Right for You?

    Tried antidepressants without enough relief? SAINT® TMS is an FDA-cleared, fMRI-guided treatment for adults with major depressive disorder who have not improved enough with antidepressant medication.

    SAINT® uses a personalized brain target and delivers treatment over five consecutive days. It differs from standard TMS in its targeting approach, treatment schedule, and research background. In a small randomized trial, 11 of 14 people receiving active treatment reached remission at the four-week assessment, compared with 2 of 15 receiving sham treatment. Results vary, and a five-day treatment course does not guarantee remission in five days.

    How SAINT® Works and How It Differs From Conventional TMS

    SAINT® is an FDA-cleared treatment for adults with major depressive disorder who have not improved on antidepressants in the current episode. This video explains how it works, and how it differs from conventional TMS.

    Conventional TMS usually means about 30 visits over 6 to 9 weeks. SAINT is five visits over five days.

    What makes it different: SAINT is the only FDA-cleared depression treatment that uses an fMRI scan to personalize the stimulation target to your individual brain. A 45-minute scan maps your brain and identifies the specific circuit linked to depression. Treatment is then delivered as ten 10-minute sessions per day, with 50-minute breaks between them, across five consecutive days.

    In clinical trials, 79% of participants reached remission, with an average of 2.6 days to remission. SAINT is generally well tolerated; the most common side effects reported were mild headache and temporary scalp discomfort at the treatment site.

    SAINT® at Neuro Wellness TMS Centers of America

    Coral Springs, Florida
    Free benefits check · Self-pay options available
    Call or Text: 954-827-9793

    Sources: Cole et al., American Journal of Psychiatry 2020;177:716-726 and 2022;179(2):132-141. magnusmedical.com/depression-therapy. PubMed 34711062. FDA 510(k) K220177.

    Insurance coverage for SAINT is currently limited and varies by plan. Individual results may vary. This video is educational and is not medical advice. Talk to a qualified clinician about whether SAINT is appropriate for you. If you are in crisis, call or text 988.

    Frequently Asked Questions

    What are the signs of treatment-resistant depression?

    The primary sign is inadequate response to at least two antidepressant trials of adequate dose and duration. Other signs include persistent symptoms despite medication, partial response that plateaus, recurring episodes despite treatment, and side effects that prevent adequate dosing. A psychiatric evaluation can confirm whether past trials were adequate.

    How do I know if my depression is treatment-resistant?

    If you've tried two or more antidepressants at adequate doses for 6-8 weeks each and your depression hasn't improved adequately, you may meet the definition. A psychiatric evaluation can review your medication history, confirm whether trials were adequate, and recommend next steps.

    Is treatment-resistant depression a separate diagnosis?

    No. Treatment-resistant depression is a description of your treatment history, not a separate diagnosis. It means standard antidepressants haven't worked adequately, and other options may be appropriate. It does not mean your depression cannot be treated.

    What counts as an adequate antidepressant trial?

    An adequate trial generally means taking an antidepressant at a therapeutic dose (not just a starting dose) consistently for about 6-8 weeks. A medication stopped early because of side effects is usually considered an incomplete trial, not a failed one.

    What should I do if I think I have treatment-resistant depression?

    Ask for a comprehensive psychiatric evaluation. This confirms whether past trials were adequate, screens for conditions that can mimic treatment resistance, and identifies what to try next. Options include TMS, SAINT®, SPRAVATO®, medication optimization, and psychotherapy.

    SAINT® is delivered only by verified providers on the Magnus Medical system. Programs described as SAINT “alternatives”, “equivalents” or “fMRI-guided accelerated TMS” are not SAINT®, are not affiliated with us, and SAINT® results do not apply to them. Read our SAINT® disclaimer.

    Have questions about whether TMS may be appropriate for you?

    Speak with our clinical team. A free consultation is the best way to get answers specific to your situation.